Cutler Group LP Neuro Bo Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Call Options

1 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Jul 19, 2021
BUY
$2.74 - $4.63 $10,960 - $18,520
4,000 New
4,000 $2,000

About NeuroBo Pharmaceuticals, Inc.

NRBO Quotes by TradingView
  • Ticker NRBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 888,693
  • Market Cap $1.97M
  • Description
  • NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...
More about NRBO
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email